
Pharmacies Bridge the Diagnostic Dead Zone Through Health Monitoring, Diagnostic Testing
With patients and pharmacists existing in new territories since the COVID-19 pandemic, at-home diagnostic testing has come a long way in improving the potential for convenient access to care.
As the traditional health care system faces increasing strain, the role of the independent pharmacist is undergoing a fundamental transformation from a medication dispenser to a proactive health advisor. This evolution is being driven by the rise of at-home diagnostic testing, which allows pharmacies to act as frontline health monitoring destinations and resources for patient insight.
“The traditional health care system really has a triage problem and the numbers make it undeniable,” Tim Drapeau, CEO of CLIAwaived Inc, told Drug Topics. “According to surveys, it now takes an average of about 30 days to schedule a physician appointment. That’s up 19% since 2022, 48% since 2004. For specialists, it's worse. Cardiology appointments wait, on average, 33 days; OBGYN is 42 days; gastroenterology, 40 days.”
In the latest episode of the Over the Counter podcast, Drapeau discusses how new diagnostic tools are shifting the pharmacy business model from transaction-based to relationship-based. By offering diagnostic kits for chronic conditions, metabolic health, and more, pharmacies can create a consultation revenue stream independent of squeezed, third-party prescription reimbursements.
A primary driver for this shift is the growing "diagnostic dead zone"—the period between a patient feeling unwell and their ability to secure a physician appointment, which now takes an average of 30 days, as Drapeau notes. He told us that while the COVID-19 pandemic normalized self-collection and at-home testing for 150 million Americans, a confidence gap remains regarding the interpretation of results.
Stay tuned for weekly podcast episodes of
Don’t get left behind: Sign up today for our






























